Company intelligence / Profile preview

Molecular Solutions

Ownership: Private
Development stage: Commercial

Overview

Molecular Solutions is an active company providing integrated software platforms to streamline and enhance the drug discovery and development process in pharmaceutical research. Their offerings include advanced tools for genomics/proteomics data analysis, computational chemistry/drug design using AI/ML approaches, electronic lab notebooks/LIMS systems integration as well as virtual reality solutions tailored to pharma R&D needs. The company focuses on enabling efficiency and collaboration in multidisciplinary research environments[2].

Therapeutic areas: Other
Modalities: Not directly applicable (company provides software solutions for drug discovery and development, not therapeutics themselves)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Molecular Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molecular Solutions.

Explore the full profile